Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 146, Issue 4, 2013, Pages 781-787

  Nentwich, Michael F ^a   Bohn, Benjamin A ^a   Uzunoglu, Faik G ^a   Reeh, Matthias ^a   Quaas, Alexander ^a   Grob, Tobias J ^a   Perez, Daniel ^a   Kutup, Asad ^a   Bockhorn, Maximilian ^a   Izbicki, Jakob R ^a   Vashist, Yogesh K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER STAGING; CONFERENCE PAPER; DISTANT METASTASIS; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADICAL RESECTION;

10.2; 10.4; COMPUTED TOMOGRAPHIC; CT; NON-SMALL CELL LUNG CANCER; NSCLC; TNM; TUMOR, NODES, AND METASTASIS; UICC; UNION FOR INTERNATIONAL CANCER CONTROL; YEAR SURVIVAL RATE; YSR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884418089     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.04.037     Document Type: Conference Paper

References (22)

1. L.H. Sobin, M. Gospodarowicz, and C. Wittekind TNM Classification of Malignant Tumours 7th ed 2010 Wiley-Blackwell Hoboken, NJ
2. K. Chansky, J.P. Sculier, J.J. Crowley, D. Giroux, J. Van Meerbeeck, and P. Goldstraw The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer J Thorac Oncol 4 2009 792 801
3. B.J. Dicken, K. Graham, S.M. Hamilton, S. Andrews, R. Lai, and J. Listgarten Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques Ann Surg 243 2006 64 73 (Pubitemid 43054056)
4. M. Ishii, M. Ota, S. Saito, Y. Kinugasa, S. Akamoto, and I. Ito Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer Int J Colorectal Dis 24 2009 1069 1074
5. A. Arnaout-Alkarain, H.J. Kahn, S.A. Narod, P.A. Sun, and A.N. Marks Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer Mod Pathol 20 2007 183 191 (Pubitemid 46422172)
6. G. Goeckenjan, H. Sitter, M. Thomas, D. Branscheid, M. Flentje, and F. Griesinger Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society Pneumologie 65 2011 39 59
7. T. Naruke, K. Suemasu, and S. Ishikawa Lymph node mapping and curability at various levels of metastasis in resected lung cancer J Thorac Cardiovasc Surg 76 1978 832 839 (Pubitemid 9084851)
8. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
9. S. Heon, and B.E. Johnson Adjuvant chemotherapy for surgically resected non-small cell lung cancer J Thorac Cardiovasc Surg 144 2012 S39 S42
10. J.M. Brechot, S. Chevret, M.C. Charpentier, C. Appere de Vecchi, F. Capron, and J. Prudent Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: correlation with TNM stage and disease free and overall survival Cancer 78 1996 2111 2118 (Pubitemid 26367603)
11. T.W. Shields Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung Surg Gynecol Obstet 157 1983 185 190
12. N.S. Goldstein, A. Mani, G. Chmielewski, R. Welsh, and S. Pursel Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung Am J Clin Pathol 112 1999 391 402 (Pubitemid 30214780)
13. T. Hanagiri, M. Takenaka, S. Oka, Y. Shigematsu, Y. Nagata, and H. Shimokawa Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer Eur Surg Res 47 2011 211 217
14. K. Funai, H. Sugimura, T. Morita, Y. Shundo, K. Shimizu, and N. Shiiya Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma Ann Surg Oncol 18 2011 2968 2972
15. S. Gabor, H. Renner, H. Popper, U. Anegg, O. Sankin, and V. Matzi Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer Eur J Cardiothorac Surg 25 2004 439 442 (Pubitemid 38340584)
16. E. Ruffini, S. Asioli, P.L. Filosso, L. Buffoni, M.C. Bruna, and C. Mossetti Significance of the presence of microscopic vascular invasion after complete resection of stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-size categories: did the 2009 7th edition of the TNM staging system miss something? J Thorac Oncol 6 2011 319 326
17. T. Tsuchiya, S. Hashizume, S. Akamine, M. Muraoka, S. Honda, and K. Tsuji Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer Chest 132 2007 170 177 (Pubitemid 47068218)
18. T.T. Pechet, S.R. Carr, J.E. Collins, H.E. Cohn, and J.L. Farber Arterial invasion predicts early mortality in stage I non-small cell lung cancer Ann Thorac Surg 78 2004 1748 1753 (Pubitemid 39423546)
19. J. Wang, J. Chen, X. Chen, B. Wang, K. Li, and J. Bi Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis PLoS One 6 2011 e28844
20. T. Tsuchiya, S. Akamine, M. Muraoka, R. Kamohara, K. Tsuji, and S. Urabe Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy Lung Cancer 56 2007 341 348 (Pubitemid 46679089)
21. R. Arriagada, A. Auperin, S. Burdett, J.P. Higgins, D.H. Johnson, and T. Le Chevalier Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data Lancet 375 2010 1267 1277
22. J.P. Pignon, H. Tribodet, G.V. Scagliotti, J.Y. Douillard, F.A. Shepherd, and R.J. Stephens Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559